Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

PvP Biologics

Request full access

Developing a highly-effective therapeutic that reduces the burden of living with celiac disease

San Diego, United StatesFounded 2016Biotech & Life Sciences

About PvP Biologics

PvP Biologics is a biotechnology company focused on developing innovative treatments for celiac disease, a condition affecting approximately 2.4 million Americans. The company's core product, KumaMax, is an oral enzyme designed to break down the immuno-reactive parts of gluten in the stomach, thereby preventing the painful symptoms and intestinal damage caused by accidental gluten ingestion. PvP Biologics operates in the healthcare and biotechnology market, primarily serving patients diagnosed with celiac disease who struggle to maintain a strict gluten-free diet. The business model revolves around the development and commercialization of this therapeutic enzyme, with revenue generated through product sales and potential licensing agreements. The technology behind KumaMax was invented at the Institute for Protein Design at the University of Washington and is exclusively licensed by PvP Biologics.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
1
Open positions
None listed
Dealroom signal
58.9/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotechnology, Spinout, Biotech and Pharma, proteomics, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Feb 2020 $0 — Takeda ↗
OtherOther financing Jan 2018 $0 — Sahsen Ventures —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

PvP Biologics website traffic

Latest recorded traffic for PvP Biologics is 250 monthly website visits, up 4.2% over the last three months. PvP Biologics's team declined 66.7% over the past year.

Latest monthly visits250 3-month web change+4.2% 1-year team growth-66.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

PvP Biologics in the San Diego ecosystem

Live from Dealroom

The PvP Biologics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Takeda

Other known investors2 additional known investors

  • Sahsen Ventures
  • University of Washington Institute for Protein Design
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Diego HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about PvP Biologics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See PvP Biologics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.